HIV Experts & Evidence™

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

Meeting Slides

Clinical Practice Guidelines

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services (DHHS).

HIV Testing.

Centers for Disease Control and Prevention (CDC).

Interim Guidance for COVID-19 and Persons With HIV.

DHHS. June 2020.

Clinical Resources


Emory University’s Rollins School of Public Health, Gilead Sciences, Inc., and the Center for AIDS Research at Emory University (CFAR).

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco.

HEP Drug Interactions.

University of Liverpool. Last reviewed December 2020.

National Harm Reduction Coalition.

Patient Resources

HIV Basics

Centers for Disease Control and Prevention (CDC).

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum.

Positively Aware

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of up-to-date HIV-treatment information for people living with HIV/AIDS, as well as an educational site for HIV caregivers.

Project Inform

Project Inform is an HIV and hepatitis C advocacy group fighting for effective treatments and high quality, affordable health care. It provides up-to-date information to help people make the best choices regarding their treatment and care.

Suggested Readings

Integrating Mental Health Care for People Living With HIV.

Carvalhal A. Health Care: Current Reviews. 2015;3(1).

Immediate initiation of antiretroviral therapy in the outpatient clinic.

Coffey S, Bacon O. HIV InSite. Updated May 2020.

Rapid antiretroviral therapy: time for a new standard of care.

Coffey S, et al. Clin Infect Dis. 2020 (Epub ahead of print).

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable.

Eisinger RW, et al. JAMA. 2019;321(5):451-452.

Pathways to health: an examination of HIV-related stigma, life stressors, depression, and substance use.

Glynn TR, et al. Int J Behav Med. 2019;26(3):286-296.

Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014.

Gokhale RH, et al. AIDS Behav. 2019;23(12):3452-3459.

A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.

Halperin J, et al. Open Forum Infect Dis. 2019;6(4):ofz161.

A strategy for PrEP clinicians to manage ambiguous HIV test results during follow-up visits.

Smith DK, et al. Open Forum Infect Dis. 2018;5(8):ofy180.

Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.

Stone. VE. Curr HIV/AIDS Rep. 2005;2(4):189-193.

Evolving Models of HIV Care - Part 1

Rapid ART Initiation: A Key Strategy for Ending the HIV Epidemic

Evolving Models of HIV Care - Part 2

Overcoming Barriers: Successful Rapid ART Initiation

Activity for event:The Rapid ART Standard of Care: From Evidence to Healthcare Equity

Evolving Models of HIV Care (Volume 3)

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes


Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

A Critical Appraisal of Non-Invasive Technologies in NASH

Informing the Future of NASH Diagnosis and Assessment

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Virologic Failure in HIV

An Updated Clinician’s Guide to Assessment and Management

Applying HIV Advances in Practice

What the Pharmacist Needs to Know

Buffing Up on New and Emerging ART

A Look at the Changing HIV Playing Field

Pharmacy PrEP Education

A “How To” Series Spanning Policy to Practice


Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Long-Acting Injectable PrEP:

Bringing HIV Prevention to a New Level

PrEParing to End the Epidemic

Optimizing HIV Prevention in Primary Care

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

Answers to Everyday Practice Challenges in HIV Medicine

A Phone-a-Friend CME Series – Volume 2

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice